A Open-Label Long-Term Extension Study To Evaluate The Safety And Efficacy Of Venlafaxine Er In Adult Outpatients With Major Depressive Disorder [EXTENSION STUDY OF 700207103]
Phase of Trial: Phase III
Latest Information Update: 23 May 2016
Price : $35 *
At a glance
- Drugs Venlafaxine (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions
- Sponsors Pfizer
- 20 Feb 2014 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov record.
- 15 Jan 2013 New trial record
- 02 Mar 2012 Trial status changed from not yet recruting to recruiting.